CD274 and neoplasm: Therefore, further large-scale studies are warranted to perform more detailed analyses with blood and tumor samples and to confirm the utility of our findings also in the subgroups of patients with less frequent characteristics, such as females, non-smokers, those with positive driver gene mutations, and those treated with PD-L1 inhibitors.